I en farmakokinetisk populationsundersøgelse af 928 patienter med angina pectoris og raske forsøgspersoner vurderedes indflydelsen af forskellige faktorer på ranolazins farmakokinetik.
The influence of various factors on the pharmacokinetics of ranolazine was assessed in a population pharmacokinetic evaluation in 928 angina patients and healthy subjects.